– GEN’s Editor-in-Chief John Sterling interviews Dr. Lennart Mucke from the Gladstone Institute of Neurological Disease.

Previous articleAllergan to Pay $370M for Esprit Pharma
Next articleIbis Awarded $4.2M for Biodefense Applications Development